Professor Michael Seckl

Attached To

Imperial Private Healthcare

part of

Imperial College Healthcare NHS Trust

London, UK

Consultant Oncologist, Professor of Molecular Cancer Medicine

London, UK


  • Gynaecological Oncology (Rare Ovarian Cancers)
  • Gestational Trophoblastic disease / Neoplasia
  • Germ Cell Tumours (male & female)
  • Testicular Tumours
  • Lung Cancer
  • Adult Solid Tumours
  • Urological Cancers (rare forms)

Training, Certification & Fellowship

  • Medical Training – University of London  and University of London Hospitals, UK
  • Specialist training in Medical Oncology
  • PhD in Biochemistry & Cancer Biology – University of London, UK

Professional Profile

  • Professor Seckl is the Director of Charing Cross / Imperial College Trophoblastic Disease & Malignant Ovarian Germ Cell Tumour Centre (MOGCT) and Supraregional Tumour Marker Assay Service.
  • He is also the director of Postgraduate studies for the Department of Surgery and Cancer and he leads the Imperial Experimental Cancer Medicine Centre.
  • He currently also heads Molecular Oncology with its associated Lung Cancer Research Team.
  • He became Director of the National Gestational trophoblastic Disease Service.
  • He has also established a new national service for malignant ovarian germ cell tumours.
  • He leads the gynaecological cancer theme of the European Rare Adult Cancer Reference Network (EURACAN).
  • He has chaired / organised many national and international meetings related to lung cancer, cell signalling and trophoblastic disease.